Press release
Investigation announced for Investors in shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)
An investigation for investors in Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) shares over potential securities laws violations.
Investors who purchased shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Intercept Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
New York based Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Intercept Pharmaceuticals, Inc. reported that its annual Total Revenue rose from $179.8 million in 2018 to $252.00 million in 2019 and that its normalized Loss increased from $309.24 million in 2019 to $344.68 million in 2019.
On October 8, 2020, news outlets reported that Intercept Pharmaceuticals, Inc. was “facing an investigation from the U.S. Food and Drug Administration over the potential risk of liver injury in patients taking Ocaliva, [Intercept’s] treatment for primary biliary cholangitis, a rare, chronic liver disease.”
Shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) declined from $125.00 per share in late 2019 to as low as $27.83 per share on October 23, 2020.
Those who purchased shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) here
News-ID: 2172079 • Views: …
More Releases from Shareholders Foundation
Lawsuit ALERT: Investors who lost money with shares of Microvast Holdings, Inc. …
An investor, who purchased shares of Microvast Holdings, Inc. (NASDAQ: MVST), filed a lawsuit over alleged violations of Federal Securities Laws by Microvast Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Microvast Holdings, Inc. (NASDAQ: MVST) have certain options and for certain investors are short and strict deadlines running. Deadline: September 21, 2026. NASDAQ: MVST investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
SES AI Corporation (NYSE: SES) Investor Alert: Deadline in Lawsuit on June 26, 2 …
A deadline is coming up on June 26, 2026 in the lawsuit filed for certain investors of SES AI Corporation (NYSE: SES) over alleged securities laws violations by SES AI Corporation.
Investors who purchased shares of SES AI Corporation (NYSE: SES) have certain options and there are strict and short deadlines running. Deadline: June 26, 2026. SES AI Corporation (NYSE: SES) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
Medpace Holdings, Inc. (NASDAQ: MEDP) Investor Alert: Deadline in Lawsuit on Jun …
A deadline is coming up on June 8, 2026 in the lawsuit filed for certain investors of Medpace Holdings, Inc. (NASDAQ: MEDP) over alleged securities laws violations by Medpace Holdings, Inc. (NASDAQ: MEDP).
Investors who purchased shares of Medpace Holdings, Inc. (NASDAQ: MEDP) have certain options and there are strict and short deadlines running. Deadline: June 8, 2026. Medpace Holdings, Inc. (NASDAQ: MEDP) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors who lost money with shares of Enphase Energy, Inc. ( …
An investor, who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH), filed a lawsuit over alleged violations of Federal Securities Laws by Enphase Energy, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH) have certain options and for certain investors are short and strict deadlines running. Deadline: April 20, 2026. NASDAQ: ENPH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Intercept
Non alcoholic Steatohepatitis Market Is Going to Boom |• Intercept Pharmaceuti …
Worldwide Market Reports has recently released a comprehensive research study titled "Non alcoholic Steatohepatitis Market Size and Forecast 2026-2033: Breakdown by Manufacturers, Key Regions, Types, and Applications." The report has been developed using a combination of primary and secondary research methodologies, ensuring a detailed and accurate analysis. Drawing insights from both historical data and future projections, the study highlights the expected growth of the Non alcoholic Steatohepatitis market in terms…
INTERCEPT Announces Insights: Evaluating Microsoft Azure's Suitability for Small …
Image: https://www.abnewswire.com/upload/2025/11/d29d7b684fbbdd3fce21ce70d19d0c60.jpg
Small businesses often lack sufficient resources to leverage as they evolve. This is why they should continually seek ways to improve efficiency and optimize their operations to the best possible extent. For a company to have access to its datasets, it needs to have the right cloud infrastructure. There are many cloud options that businesses can consider, but Microsoft Azure has proven to be the best so far, as…
Legal Intercept System Market Is Booming Worldwide | Atos, SS8 Networks
The latest study released on the Global Legal Intercept System Market by HTF MI evaluates market size, trend, and forecast to 2030. The Legal Intercept System market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key…
Investigation announced for Long-Term Investors in Intercept Pharmaceuticals, In …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Intercept Pharmaceuticals, Inc..
Investors who are current long term investors in Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in (NASDAQ: ICPT stocks follows a lawsuit filed against Intercept Pharmaceuticals, Inc. over…
Lawsuit filed for Investors in shares of Intercept Pharmaceuticals, Inc. (NASDAQ …
An investor, who purchased shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), filed a lawsuit over alleged violations of Federal Securities Laws by Intercept Pharmaceuticals, Inc.
Investors who purchased shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) have certain options and for certain investors are short and strict deadlines running. Deadline: January 4, 2021. NASDAQ: ICPT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
New York based…
Submarine Active Intercept and Ranging System Market to Witness Robust Expansion …
LP INFORMATION offers a latest published report on Submarine Active Intercept and Ranging System Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Submarine Active Intercept and Ranging System market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024,…
